Our Research

BioPolyTec;

Plasma Biotal Limited are part of Bio-PolyTec, which is a €1million, two year, EU FP7 research project, launched in December 2013. Its aims are to progress the commercial availability of bioresorbable and drug-eluting medical implants such as tissue engineering scaffolds and orthopaedic fixation devices.

Bioresorbable devices are temporary implants, gradually breaking-down inside the body when they are no longer needed into simple molecules such as water and carbon dioxide - leaving no trace of the original device in the patient. Benefits for the patient include no need for a second operation to remove the device, better biocompatibility than traditional metallic devices and due to the ability to add antibacterial or antibiotic drugs and to control the release rate at the implant site, such devices can reduce the number of post-operative complications and open up possibilities for new therapies. However, despite having huge potential to improve patient outcomes whilst reducing healthcare costs, high manufacturing costs have so far hindered development and availability of bioresorbable medical implants.

Bioresorbable materials have a high cost and are difficult to process. While there are already many established bioresorbable medical devices on the market, high development costs and difficulties in processing the materials have hindered growth of the industry. For medical reasons, additives and plasticisers used in technical plastics cannot be utilised making the identification and control of suitable processing conditions extremely challenging. Quality assessment usually requires lengthy off-line testing which results in high scrap rates, long lead times and lengthy and expensive process development. Currently, long and expensive trial and error periods are required to establish process settings and yet result in typical scrap rates of 25-30%, in many cases this is prohibitive to successful commercialisation.

For more information visit the Bio-PolyTec Website

Recent Published Research using CAPTAL ®